Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts

Kyriakos P. Papadopoulos, Nicole Suciu-Foca, Charles S. Hesdorffer, Sorina Tugulea, Antonella Maffei, Paul E. Harris

Research output: Contribution to journalArticle

Abstract

Structural analysis of naturally processed peptides bound to the HLA class I and class II molecules of chronic myeloid leukemia (CML) blast cells was performed to characterize the antigen processing and autoantigen repertoire in this hematopoietic malignancy. Self-peptides derived from the carboxy-terminal end of the breakpoint cluster region (bcr) protein, as well as several differentiation stage- and tissue-specific self-antigens characteristic of early stages of myeloid differentiation, such as c-fas, c- pirn, granulocyte-macrophage colony-stimulating factor receptor a chain, proteinase 3, and cathepsin G, were identified. A common characteristic of several of the high copy-number self-peptides identified in this study is the participation of their parent proteins in signal transduction or myeloid effector function. Because bcr-abl junctional peptides bind to a limited number of major histocompatibility complex (MHC) class I alleles, an effective peptide-based immunotherapy strategy for CML requires identification of further tumor-associated or specific peptide antigens binding to common MHC alleles such as HLA-A2. The differentiation stage- and tissue-specific MHC-bound peptides found in this study, as well as the naturally processed proteins from which they are derived, may represent autoantigens towards which T-cell responses may potentially be developed for immunotherapy of hematopoietic malignancies such as CML.

Original languageEnglish (US)
Pages (from-to)4938-4946
Number of pages9
JournalBlood
Volume90
Issue number12
StatePublished - Dec 15 1997
Externally publishedYes

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Tissue
Peptides
Molecules
Autoantigens
Major Histocompatibility Complex
Hematologic Neoplasms
Proto-Oncogene Proteins c-bcr
Immunotherapy
Granulocyte-Macrophage Colony-Stimulating Factor Receptors
Alleles
Cathepsin G
Myeloblastin
HLA-A2 Antigen
Antigens
Signal transduction
T-cells
Antigen Presentation
Structural analysis
Tumors

ASJC Scopus subject areas

  • Hematology

Cite this

Papadopoulos, K. P., Suciu-Foca, N., Hesdorffer, C. S., Tugulea, S., Maffei, A., & Harris, P. E. (1997). Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. Blood, 90(12), 4938-4946.

Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. / Papadopoulos, Kyriakos P.; Suciu-Foca, Nicole; Hesdorffer, Charles S.; Tugulea, Sorina; Maffei, Antonella; Harris, Paul E.

In: Blood, Vol. 90, No. 12, 15.12.1997, p. 4938-4946.

Research output: Contribution to journalArticle

Papadopoulos, KP, Suciu-Foca, N, Hesdorffer, CS, Tugulea, S, Maffei, A & Harris, PE 1997, 'Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts', Blood, vol. 90, no. 12, pp. 4938-4946.
Papadopoulos KP, Suciu-Foca N, Hesdorffer CS, Tugulea S, Maffei A, Harris PE. Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. Blood. 1997 Dec 15;90(12):4938-4946.
Papadopoulos, Kyriakos P. ; Suciu-Foca, Nicole ; Hesdorffer, Charles S. ; Tugulea, Sorina ; Maffei, Antonella ; Harris, Paul E. / Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. In: Blood. 1997 ; Vol. 90, No. 12. pp. 4938-4946.
@article{2ef2712823c0422b850ff9b8f7125732,
title = "Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts",
abstract = "Structural analysis of naturally processed peptides bound to the HLA class I and class II molecules of chronic myeloid leukemia (CML) blast cells was performed to characterize the antigen processing and autoantigen repertoire in this hematopoietic malignancy. Self-peptides derived from the carboxy-terminal end of the breakpoint cluster region (bcr) protein, as well as several differentiation stage- and tissue-specific self-antigens characteristic of early stages of myeloid differentiation, such as c-fas, c- pirn, granulocyte-macrophage colony-stimulating factor receptor a chain, proteinase 3, and cathepsin G, were identified. A common characteristic of several of the high copy-number self-peptides identified in this study is the participation of their parent proteins in signal transduction or myeloid effector function. Because bcr-abl junctional peptides bind to a limited number of major histocompatibility complex (MHC) class I alleles, an effective peptide-based immunotherapy strategy for CML requires identification of further tumor-associated or specific peptide antigens binding to common MHC alleles such as HLA-A2. The differentiation stage- and tissue-specific MHC-bound peptides found in this study, as well as the naturally processed proteins from which they are derived, may represent autoantigens towards which T-cell responses may potentially be developed for immunotherapy of hematopoietic malignancies such as CML.",
author = "Papadopoulos, {Kyriakos P.} and Nicole Suciu-Foca and Hesdorffer, {Charles S.} and Sorina Tugulea and Antonella Maffei and Harris, {Paul E.}",
year = "1997",
month = "12",
day = "15",
language = "English (US)",
volume = "90",
pages = "4938--4946",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts

AU - Papadopoulos, Kyriakos P.

AU - Suciu-Foca, Nicole

AU - Hesdorffer, Charles S.

AU - Tugulea, Sorina

AU - Maffei, Antonella

AU - Harris, Paul E.

PY - 1997/12/15

Y1 - 1997/12/15

N2 - Structural analysis of naturally processed peptides bound to the HLA class I and class II molecules of chronic myeloid leukemia (CML) blast cells was performed to characterize the antigen processing and autoantigen repertoire in this hematopoietic malignancy. Self-peptides derived from the carboxy-terminal end of the breakpoint cluster region (bcr) protein, as well as several differentiation stage- and tissue-specific self-antigens characteristic of early stages of myeloid differentiation, such as c-fas, c- pirn, granulocyte-macrophage colony-stimulating factor receptor a chain, proteinase 3, and cathepsin G, were identified. A common characteristic of several of the high copy-number self-peptides identified in this study is the participation of their parent proteins in signal transduction or myeloid effector function. Because bcr-abl junctional peptides bind to a limited number of major histocompatibility complex (MHC) class I alleles, an effective peptide-based immunotherapy strategy for CML requires identification of further tumor-associated or specific peptide antigens binding to common MHC alleles such as HLA-A2. The differentiation stage- and tissue-specific MHC-bound peptides found in this study, as well as the naturally processed proteins from which they are derived, may represent autoantigens towards which T-cell responses may potentially be developed for immunotherapy of hematopoietic malignancies such as CML.

AB - Structural analysis of naturally processed peptides bound to the HLA class I and class II molecules of chronic myeloid leukemia (CML) blast cells was performed to characterize the antigen processing and autoantigen repertoire in this hematopoietic malignancy. Self-peptides derived from the carboxy-terminal end of the breakpoint cluster region (bcr) protein, as well as several differentiation stage- and tissue-specific self-antigens characteristic of early stages of myeloid differentiation, such as c-fas, c- pirn, granulocyte-macrophage colony-stimulating factor receptor a chain, proteinase 3, and cathepsin G, were identified. A common characteristic of several of the high copy-number self-peptides identified in this study is the participation of their parent proteins in signal transduction or myeloid effector function. Because bcr-abl junctional peptides bind to a limited number of major histocompatibility complex (MHC) class I alleles, an effective peptide-based immunotherapy strategy for CML requires identification of further tumor-associated or specific peptide antigens binding to common MHC alleles such as HLA-A2. The differentiation stage- and tissue-specific MHC-bound peptides found in this study, as well as the naturally processed proteins from which they are derived, may represent autoantigens towards which T-cell responses may potentially be developed for immunotherapy of hematopoietic malignancies such as CML.

UR - http://www.scopus.com/inward/record.url?scp=0031442008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031442008&partnerID=8YFLogxK

M3 - Article

C2 - 9389712

AN - SCOPUS:0031442008

VL - 90

SP - 4938

EP - 4946

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -